[ET Net News Agency, 22 June 2022] CKLIFE SCIENCES (00775) rose 21.54% to HK$0.79,
breaking above the 250-D SMA of HK$0.714.
It hits an intra-day high of HK$0.79, hitting an 1-month high, and an intra-day low of
HK$0.66. The total shares traded was 19.45 million, with a value of HK$14.23m. The active
buy/sell ratio is 88:12, with net buying turnover of HK$10.64m. CHINA GALAXY INT'L SEC
(HK) accounts for greatest net responsive buying turnover of HK$104,067, with volume
weighted average price of HK$0.7. SANFULL SEC accounts for greatest net responsive selling
turnover of HK$1.23m, with volume weighted average price of HK$0.747.
The Hang Seng Index now fell 182 points, or 0.85% to 21,376; the Hang Seng China
Enterprises Index now fell 71 points, or 0.95% to 7,477; the Hang Seng TECH Index now fell
60 points, or 1.27% to 4,699; with an overall turnover of HK$17.36b.
The SSE Composite Index now fell 12 points, or 0.39% to 3,293, with an overall turnover
of RMB68.19b.
The SZSE Component Index now fell 54 points, or 0.44% to 12,369, with an overall
turnover of RMB45.62b.
Basic Information
=================
----------------------------------
Nominal 0.790 % Chg +21.54%
High 0.790 Low 0.660
Shares Tr 19.45m Turnover 14.23m
10-D SMA 0.669 %H.V 26.154
20-D SMA 0.645 VWAP 0.731
50-D SMA 0.620 RSI14 80.971
----------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
88:12, with net buying turnover of HK$10.64m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CKLIFE SCIENCES (00775) 0.790 +21.54
SIHUAN PHARM (00460) 1.260 +3.28
TRAD CHI MED (00570) 4.410 +6.52
NT PHARMA (01011) 0.238 +11.74
CSPC PHARMA (01093) 7.380 -0.81
SINO BIOPHARM (01177) 4.460 -1.76
FOSUN PHARMA (02196) 30.500 -1.61
WUXI APPTEC (02359) 99.300 -0.70
CHINARES PHARMA (03320) 5.030 +1.00
PHARMARON (03759) 72.350 +0.63
-----------------------------------------------
(ed)